Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breathing Tube-Free anesthesia could speed kidney transplant recovery

NCT ID NCT07377123

Symptom relief Sponsor: Jianxing He Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new 'tubeless' anesthesia method (using a laryngeal mask and lighter sedation) to standard breathing-tube anesthesia in 60 kidney transplant patients. The goal is to see if it reduces the need for muscle relaxants and other drugs, and improves recovery. Participants will be followed for life to track long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tubeless spontaneous ventilation anesthesia (a procedure using laryngeal mask and specific drugs like propofol, remifentanil, cisatracurium)
What this could lead to
If it works, this could lead to a safer, faster-recovering anesthesia method for kidney transplant patients, reducing side effects from muscle relaxants.
What could go wrong
This is a small, early-stage trial (60 people) at one center. The procedure may not be safer or more effective than standard anesthesia, and risks like breathing problems or inadequate anesthesia depth exist.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. No gender restriction, age 18-65 years (including upper and lower limits). 2. First-time recipient of citizen organ donation kidney transplantation. 3. Type of citizen organ donation must be Category I China (Donation after Brain Death DBD). 4. Donor and recipient blood type identical. 5. Panel reactive antibody (PRA) results negative within six months preoperatively. 6. Body mass index (BMI) \<28 kg/m². 7. No severe pulmonary ventilation or gas exchange dysfunction, preoperative pulmonary function assessment meets kidney transplantation requirements, preoperative chest CT shows no significant abnormalities. 8. No severe arrhythmia (frequent atrial fibrillation or ventricular premature beats), normal cardiac function (ejection fraction \> 50%). 9. American Society of Anesthesiologists (ASA) physical status classification ≤ III. 10. Voluntarily participate in clinical research, fully understand this study and voluntarily sign the informed consent form, and complete all trial procedures. Exclusion Criteria: 1. Combined multi-organ transplantation. 2. Previous history of organ transplantation other than kidney. 3. Living donor kidney transplantation. 4. If one of the two patients receiving a kidney from the same donor does not meet the inclusion criteria, the other patient is also excluded. 5. Previous history of mental illness, current psychological assessment does not meet transplantation criteria. 6. Other situations where the organ transplant physician assesses the patient as not suitable for transplantation. 7. Poor compliance of the recipient or other situations deemed by the researcher as unsuitable for inclusion in the trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CKD (chronic kidney disease) stage 5D are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CKD (chronic kidney disease) stage 5D Kidney transplantation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.